Nons=moker Dave Nitsche shares his journey of resilience and determination after a stage 4 lung cancer diagnosis.

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

Ginny Fagerstrom, born and raised in Nome, Alaska, describes herself as part of a community of “Inupiaq grandmas and Gold Rush grandpas.” Her life has been defined by family, friendship and community, ...

Scientists think they have discovered the reason pulmonary fibrosis patients get worse and don’t heal. Pulmonary fibrosis leads to scar tissue development in the lungs that persists until patients ...

Please provide your email address to receive an email when new articles are posted on . Lung cancer impact differs among women vs. men as it relates to experience with adverse events, mental health ...

Dietitians say you shouldn't take these vitamins in the morning More details revealed about Tiger Woods' rollover crash through arrest reports How to get rid of grass between patio stones for good How ...

With a second phase 3 win for Tyvaso in idiopathic pulmonary fibrosis (IPF), United Therapeutics is padding the case for an expansion and putting more color on its filing plans with the FDA. In the ...

A new study reveals that aging lungs may actively drive dangerous inflammation during infections like flu and COVID. Credit: Shutterstock Aging lungs may be sabotaging themselves—fueling runaway ...

IRVING, Texas, March 26, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, announced the addition ...

A compound called orcinol glucoside (OG) can reduce lung inflammation and scarring in mouse and cell models of idiopathic pulmonary fibrosis (IPF), according to the findings of a new study, which ...

Findings provide early evidence supporting potential disease-modifying activity of AP01 (inhaled pirfenidone) in patients with IPF BOSTON, March 25, 2026 (GLOBE NEWSWIRE)-- Avalyn Pharma Inc., ...